rubitecan has been researched along with Sarcoma 180 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, BC; Chen, J; Chen, ZP; Fang, F; Gong, F; Gu, W; Hu, RR; Luo, L; Tian, R; Yang, XX | 1 |
| Dong, J; Fu, Y; Gong, T; Lian, X; Lin, Q; Teng, Y; Zhang, J | 1 |
| Chen, Y; Fang, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Sha, X; Xin, H; Zhang, W | 1 |
3 other study(ies) available for rubitecan and Sarcoma 180
| Article | Year |
|---|---|
Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Camptothecin; Hydrogen-Ion Concentration; Injections, Intravenous; Lactones; Mice; Mice, Inbred ICR; Sarcoma 180; Tissue Distribution; Toxicity Tests | 2013 |
Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Transport; Caco-2 Cells; Camptothecin; Cell Culture Techniques; Drug Carriers; Drug Compounding; Endocytosis; Gastrointestinal Tract; Humans; Male; Mice, Inbred ICR; Molecular Structure; Particle Size; Polyethylene Glycols; Polyvinyls; Rats, Sprague-Dawley; Sarcoma 180; Surface Properties | 2014 |
Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Sarcoma 180; Toxicity Tests, Chronic; Xenograft Model Antitumor Assays | 2011 |